Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

Salles, Gilles; Mounier, Nicolas; de Guibert, Sophie; Morschhauser, Franck; Doyen, Chantal; Rossi, Jean‐François; Haïoun, Corinne; Brice, Pauline; Mahé, Beatrice; Bouabdallah, Réda; Audhuy, B.; Fermé, Christophe; Dartigeas, Caroline; Feugier, Pierre; Sebban, Catherine; Xerri, Luc; Foussard, Charles

doi:10.1182/blood-2008-04-153189

Public

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

Published in Blood • Sep 17, 2008

Authors:

Gilles Salles

Nicolas Mounier

Sophie de Guibert

Abstract

The FL2000 study was undertaken to evaluate the combination of the anti-CD20 monoclonal antibody rituximab with chemotherapy plus interferon in the first-line treatment of follicular lymphoma patients with a high tumor burden. Patients were randomly assigned to receive either 12 courses of the chemo...

Subject

Medicine

Rituximab

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!